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A B S T R A C T
Wautersiella falsenii is a Gram-negative, non-motile rod, which grows aerobically on common isolation
media and is the only acknowledged species among the genus Wautersiella. Two genomovars, namely 1
and 2, phenotypically indistinguishable but genotypically different, are described. To date, few case
reports detailing the clinical disease associated with W. falsenii have been reported, all describing
localized infection. To our knowledge, this study reports the ﬁrst isolation of W. falsenii genomovar 2
from a respiratory sample of an immunosuppressed man. Our hypothesis is that the patient was
harboring W. falsenii genomovar 2 and both the immunosuppression and the antimicrobial treatments
provided a chance for this organism to emerge. The clinical signiﬁcance of this result is yet to be
evaluated. Although infection with W. falsenii remains rare, this bacterium should not be underestimated
mainly because of its natural resistance to many available antimicrobials.
 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Wautersiella falsenii is a Gram-negative, non-motile rod,
positive for urease and for indole production, which grows
aerobically on common isolation media such as blood agar [1]
or MacConkey agar plates at 37 8C. Wautersiella was proposed as
monospeciﬁc genus within the family Flavobacteriaceae in 2006
[1]. W. falsenii is the only acknowledged species among the genus
Wautersiella [1]. Two genomovars, namely 1 and 2, were included
to accommodate two groups of closely related isolates from clinical
origins and with phenotypic resemblance to isolates of the genera
Chryseobacterium, Weeksella and Empedobacter and of CDC groups
II-e and II-h [2]. Recently, Zhang et al. [3] evidenced that the type
strain of the type species of the genera Empedobacter and
Wautersiella shared biochemical and phenotypical characteristics,
suggesting that they might belong to the same genus [3].
Case and discussion
The patient
The patient, a 32-year-old man, metalworker, affected by
lymphoblastic leukemia, was admitted in Hematology Unit-Pisa* Corresponding author. Tel.: +39 050995418; fax: +39 050996870.
E-mail address: cesira.giordano@gmail.com (C. Giordano).
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4.0/).(Italy) in good clinical condition for the bone marrow transplanta-
tion from his HLA-matched relative. Laboratory ﬁndings in the ﬁrst
day of hospitalization included a white blood cell count of 3500/mL,
hemoglobin 11.9 g/dL, platelet 114,000/mL. Two days later, a central
venous catheter was positioned. Due to disease relapsing in day 3, he
underwent high-dose chemotherapy with cytarabine and mitox-
antrone. On day 12, the patient developed fever (>39 8C) and a
swelling near the right axilla in day 13; he received a broad range
therapy with piperacillin/tazobactam, teicoplanin and gentamicin.
Blood was drawn for cultures and a multisensitive strain of Klebsiella
pneumoniae was isolated. Due to the persistence of fever, in day 24 a
new therapy scheme was adopted: liposomal amphotericin B,
meropenem, tigecycline, daptomycin and colistin. A wound swab,
performed on the swelling, was negative for bacteria and fungi. On
day 31, Candida antigen was detected in the serum patient. Due to
the onset of cough and cold symptoms, a microbiological monitoring
of the respiratory samples was performed on day 35 and a strain of
W. falsenii was isolated. The patient was discharged on the 42nd
hospital day, after blood transfusion, with the following home
therapy: ﬂuconazole (200 mg) twice per day, acyclovir (400 mg)
twice per day, clarithromycin (500 mg) once per day, erythropoietin
(40,000 UI) once per week and ﬁlgrastim. Laboratory ﬁndings on the
last hospital day included a white blood cell count of 2790/mL,
hemoglobin 8.1 g/dL, platelet 14,000/mL.
The respiratory samples were cultured on common isolation
media, both nutrients and selective media and were incubated ate under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Fig. 1. Phylogenetic tree based on the 16S rRNA gene sequences of the isolate described in this study (Pisa Strain) and some representative members of related genera in the
family Flavobacteriaceae, with a particular focus on the genus Wautersiella. Bootstrap percentages greater than 70%, based on maximum likelihood analyses of 1000
replications, are shown at nodes. Bar represents 10 nucleotide substitutions in 100 nucleotides.
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laser desorption ionization-time of ﬂight mass spectrometer
(MALDI-TOF MS) (Bruker Daltonics, Bremen, Germany), with a
score of 1.94 (probable genus-level identiﬁcation). Antimicrobial
susceptibility testing was performed using the Sensititre system
(Thermo Fisher Scientiﬁc). The Minimal Inhibitory Concentrations
(MICs) results were interpreted for nineteen antimicrobials, using
the EUCAST breakpoints (European Committee on Antimicrobial
Susceptibility Testing, 2014). The W. falsenii isolate was resistant to
amikacin (>16 mg/ml), amikacin-clavulanic acid (>8 mg/ml),
ampicillin-sulbactam (32 mg/ml), cefotaxime (>4 mg/ml), ceftazi-
dime (>8 mg/ml), doripenem (>8 mg/ml), gentamicin (>4 mg/ml),
imipenem (8 mg/ml) and piperacillin-tazobactam (16 mg/ml).
MICs values were not interpreted for ciproﬂoxacin (1 mg/ml),
colistin (>8 mg/ml), ertapenem (>1 mg/ml), fosfomycin (>64 mg/
ml), levoﬂoxacin (4 mg/ml), meropenem (32 mg/ml), nitrofur-
antoin (>64 mg/ml) and tigecycline (12 mg/ml). The isolate was
susceptible only to cefepime (1 mg/ml) and trimethoprim-
sulfamethoxazole (0.5 mg/ml). Accordingly, the isolate showed
phenotypic resistance to the majority of available antimicrobials.
This resistance pattern, typical of an environmental bacterium,
explains well both the predominance of this organism and lack of
response to the previously administered antimicrobials.
The identiﬁcation of colonies was conﬁrmed by 16S polymerase
chain reaction. Genomic DNA was extracted and ampliﬁed with the
primers F7bac_2deg (50-GAGTTTGAT(CT)(AC)TGGCTCAG-30, mod-
iﬁed from Lane, 1991) [4] and BAC R1492 (50-GG(CGAT)(A-
T)ACCTTGTTACGACTT-30, modiﬁed from Lane, 1991) [4].
Ampliﬁed and puriﬁed fragments were further sequenced in
both directions with proper internal primers for the bacterial 16S
rRNA gene sequence: 16SF343ND 50-TACGGGAGGCAGCAG-30;
16SF785ND 50-GGATTAGATACCCTGGTA-30; 16SR515ND 50-
ACCGCGGCTGCTGGCAC-30 [5]. Afﬁliation of sequences was ﬁrst
determined by NCBI BLAST analysis [6], then sequences were
inserted in the ARB 5.2 software [7], Silva 104 database [8] andalignment was reﬁned manually for phylogenetic studies. The 16S
rRNA gene showed 99% identity (1440/1441 bp) with W. falsenii
genomovar 2 (GeneBank accession no. AM238678). A phylogenetic
analysis of almost-complete 16S rRNA gene sequences revealed
that the isolate studied formed a distinct cluster with W. falsenii
genomovar 2, well supported by bootstrap analysis. The phyloge-
netic tree showing the results of the performed phylogenetic
analysis is shown in Fig. 1.
Accession number
Nucleotide sequence data was deposited to the European
Nucleotide Archive (ENA) under accession number LN886517.
Conclusions
Little is known regarding the epidemiology and clinical
signiﬁcance of this organism. To date, few case-reports detailing
the clinical disease associated with W. falsenii were reported, all
describing localized infection. Twenty-six strains of W. falsenii
isolated from the ﬁrst publication were from clinical origin [1]. Of
these, 5 were isolated from blood cultures, 1 from ear discharge, 1
from oral cavity, 1 from pleural ﬂuid, 2 from pus, 2 from respiratory
tract (subsp. genomovar 1), 1 from vaginal swab, 5 from wound
cultures, and 8 were from an unknown origin [1]. In the year 2012,
the ﬁrst isolation of W. falsenii from a urine sample of an infant
with a complicated urinary tract infection was described [9]. W.
falsenii was found in a respiratory sample from a cystic ﬁbrosis
patient, without an individual interpretation of its clinical
signiﬁcance [10]. In 2015, was also isolated from a cervical neck
abscess sample from a female with acute otitis media [11]. W.
falsenii was implied as a potential agent of hospital-acquired
infections via hospital carpet [12]. The organism was also isolated
from soil, polluted sediment, rodent skin [13] and appears in two
articles on potential pathogenic agents in metal working aerosols
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metalworking industry utilizes recirculating metalworking ﬂuids
containing, in addition to chemical substances, bacteria of
potential epidemiologic signiﬁcance [16,17]. In the past years,
epidemiological assessments with machine operators in the
metalworking industry identiﬁed remarkable respiratory effects
(e.g. Refs. [16–20]). This supports our hypothesis: the patient may
have contracted W. falsenii in the workplace and afterwards W.
falsenii may have found in the patient a pleasant host in which
replicate. Indeed, the patient was recovered in a protective
isolation: he was in a single room with HEPA ﬁltration and a
controlled ventilation system; accordingly, no clear source of
infection was identiﬁed. Microbiological sampling of room
surfaces and water ﬁlters did not give results for W. falsenii. The
infection described in this study was not severe; however,
respiratory infections should be considered important, since they
may be the source of more severe infections, particularly in
immunocompromised patients.
To our knowledge, this study reports the ﬁrst isolation of W.
falsenii genomovar 2 from a respiratory sample. We speculate that
our patient was harboring W. falsenii genomovar 2 and both the
immunosuppression and the antimicrobial treatments provided a
chance for this organism to emerge. The signiﬁcance of this result
in terms of clinical microbiology is yet to be evaluated. Although
infection with W. falsenii remains rare, this bacterium should not
be underestimated, mainly because of its natural resistance to
many available antibiotics. Little is known regarding the epidemi-
ology of this genus and nothing about the clinical differences
between W. falsenii genomovar 1 and W falsenii genomovar 2
infections. Further studies are necessary to establish the clinical
signiﬁcance, resistance patterns, and carrier rate of this emerging
opportunistic pathogen.
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